For VEON Ltd. [VEON], Analyst sees a rise to $2.70. What next?

VEON Ltd. [NASDAQ: VEON] traded at a low on 10/13/21, posting a -1.30 loss after which it closed the day’ session at $2.27. The company report on October 12, 2021 that VEON’s Beeline and Leading Medical Institute Join Forces to Redefine Future of Medical Diagnostics Through AI.

VEON’s Beeline Partners with Sechenov University to Create New AI Laboratory.

VEON Ltd. (NASDAQ: VEON) (Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announces that its mobile operator in Russia, Beeline, has signed an agreement with Sechenov University to create an Artificial Intelligence (AI) Laboratory for research and development into new technology solutions for healthcare, aiming to simplify and accelerate high-precision diagnostic.

The results of the trading session contributed to over 4150310 shares changing hands. Over the past one week, the price volatility of VEON Ltd. stands at 3.13% while the volatility over the past one month is 3.33%.

The market cap for VEON stock reached $4.04 billion, with 1.75 billion shares outstanding and 907.67 million shares in the current float. Compared to the average trading volume of 9.94M shares, VEON reached a trading volume of 4150310 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about VEON Ltd. [VEON]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VEON shares is $2.52 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VEON stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for VEON Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 26, 2021. The new note on the price target was released on January 27, 2021, representing the official price target for VEON Ltd. stock.

The Average True Range (ATR) for VEON Ltd. is set at 0.08, with the Price to Sales ratio for VEON stock in the period of the last 12 months amounting to 0.50. The Price to Book ratio for the last quarter was 9.87, with the Price to Cash per share for the same quarter was set at 0.71. Price to Free Cash Flow for VEON in the course of the last twelve months was 6.68 with Quick ratio for the last quarter at 0.50.

How has VEON stock performed recently?

VEON Ltd. [VEON] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.79. With this latest performance, VEON shares gained by 3.65% in over the last four-week period, additionally plugging by 26.11% over the last 6 months – not to mention a rise of 66.91% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VEON stock in for the last two-week period is set at 63.49, with the RSI for the last a single of trading hit 64.01, and the three-weeks RSI is set at 62.84 for VEON Ltd. [VEON]. The present Moving Average for the last 50 days of trading for this stock 2.02, while it was recorded at 2.29 for the last single week of trading, and 1.83 for the last 200 days.

VEON Ltd. [VEON]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and VEON Ltd. [VEON] shares currently have an operating margin of +19.17 and a Gross Margin at +52.27. VEON Ltd.’s Net Margin is presently recorded at -4.37.

Return on Total Capital for VEON is now 13.26, given the latest momentum, and Return on Invested Capital for the company is -3.99. Return on Equity for this stock declined to -49.97, with Return on Assets sitting at -2.34. When it comes to the capital structure of this company, VEON Ltd. [VEON] has a Total Debt to Total Equity ratio set at 6,169.33. Additionally, VEON Total Debt to Total Capital is recorded at 98.40, with Total Debt to Total Assets ending up at 69.11. Long-Term Debt to Equity for the company is recorded at 5,418.40, with the Long-Term Debt to Total Capital now at 86.43.

Reflecting on the efficiency of the workforce at the company, VEON Ltd. [VEON] managed to generate an average of -$7,015 per employee. Receivables Turnover for the company is 10.21 with a Total Asset Turnover recorded at a value of 0.53.VEON Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 0.60.

Insider trade positions for VEON Ltd. [VEON]

There are presently around $855 million, or 27.40% of VEON stock, in the hands of institutional investors. The top three institutional holders of VEON stocks are: EXOR CAPITAL LLP with ownership of 78,347,333, which is approximately 5.799% of the company’s market cap and around 39.60% of the total institutional ownership; MORGAN STANLEY, holding 50,621,996 shares of the stock with an approximate value of $114.91 million in VEON stocks shares; and TT INTERNATIONAL, currently with $93.88 million in VEON stock with ownership of nearly 9.421% of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in VEON Ltd. stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 64 institutional holders increased their position in VEON Ltd. [NASDAQ:VEON] by around 53,742,584 shares. Additionally, 39 investors decreased positions by around 20,952,992 shares, while 23 investors held positions by with 301,807,694 shares. The mentioned changes placed institutional holdings at 376,503,270 shares, according to the latest SEC report filing. VEON stock had 20 new institutional investments in for a total of 9,261,774 shares, while 10 institutional investors sold positions of 1,137,722 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam